Insiders · CRBP

CRBP insider transactions

Corbus Pharmaceuticals Holdings Inc. (CRBP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CRBP

• 52d
  Chief Medical Officer Smethurst Dominic sold $50,601 worth of shares (6,097 units at $8.30), decreasing direct ownership by 6% to 89,790 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 66d
  Chief Operating Officer Hodgson Ian sold $6,253 worth of shares (847 units at $7.38), decreasing direct ownership by 2% to 51,080 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 66d
  Chief Financial Officer Moran Sean F. sold $36,588 worth of shares (4,701 units at $7.78), decreasing direct ownership by 5% to 96,694 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 66d
  Chief Executive Officer Cohen Yuval sold $107,952 worth of shares (13,871 units at $7.78), decreasing direct ownership by 7% to 174,316 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 80d
  Chief Medical Officer Smethurst Dominic sold $26,575 worth of shares (3,285 units at $8.09), decreasing direct ownership by 3% to 95,887 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 80d
  Chief Operating Officer Hodgson Ian sold $19,537 worth of shares (2,415 units at $8.09), decreasing direct ownership by 4% to 51,927 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 99d
  Chief Operating Officer Hodgson Ian was granted 28,365 shares, increasing direct ownership by 109% to 54,342 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 99d
  Chief Executive Officer Cohen Yuval was granted 50,000 shares, increasing direct ownership by 36% to 188,187 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 99d
  Chief Medical Officer Smethurst Dominic was granted 28,365 shares, increasing direct ownership by 40% to 99,172 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 99d
  Chief Financial Officer Moran Sean F. was granted 28,082 shares, increasing direct ownership by 38% to 101,395 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 131d
  Large owner Cormorant Asset Management, Lp sold $344,012 worth of shares (30,029 units at $11.46) (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 180d
  Chief Executive Officer Cohen Yuval exercised 27,633 shares at a strike of $4.26 and sold $471,204 worth of shares (27,633 units at $17.05) (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 180d
  Chief Financial Officer Moran Sean F. exercised 12,981 shares at a strike of $4.26 and sold $220,937 worth of shares (12,981 units at $17.02) (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 186d
  Director Altmeyer Anne exercised 1,060 shares at a strike of $4.80 and sold $21,730 worth of shares (1,060 units at $20.50) (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 327d
  Director Altmeyer Anne sold $10,096 worth of shares (1,392 units at $7.25) and was granted 4,800 shares, increasing direct ownership by 122% to 6,191 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 327d
  Director Jenkins John Kenneth sold $20,465 worth of shares (2,783 units at $7.35) and was granted 4,800 shares, increasing direct ownership by 72% to 4,833 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 327d
  Director Kung Winston was granted 4,800 shares, increasing direct ownership by 86% to 10,366 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 327d
  Director Ben Yong was granted 4,800 shares, increasing direct ownership by 172% to 7,583 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 327d
  Director Holmer Alan F was granted 4,800 shares, increasing direct ownership by 82% to 10,629 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 327d
  Director Jacques Rachelle Suzanne was granted 4,800 shares, increasing direct ownership by 172% to 7,583 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 403d
  New insider Hodgson Ian claimed ownership of 25,977 shares (SEC Form 3)

  3 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 414d
  Chief Medical Officer Smethurst Dominic sold $43,330 worth of shares (6,393 units at $6.78), decreasing direct ownership by 8% to 70,807 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 431d
  Chief Financial Officer Moran Sean F. sold $24,446 worth of shares (2,792 units at $8.76), decreasing direct ownership by 4% to 73,313 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 431d
  Chief Executive Officer Cohen Yuval sold $62,465 worth of shares (7,134 units at $8.76), decreasing direct ownership by 5% to 138,187 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 445d
  Chief Medical Officer Smethurst Dominic was granted 27,200 shares, increasing direct ownership by 54% to 77,200 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 445d
  Chief Financial Officer Moran Sean F. was granted 27,500 shares, increasing direct ownership by 57% to 76,105 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 445d
  Chief Executive Officer Cohen Yuval was granted 68,100 shares, increasing direct ownership by 88% to 145,321 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 578d
  Large owner Cormorant Asset Management, Lp bought $7,003,761 worth of shares (350,000 units at $20.01) (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 613d
  Director Kung Winston was granted 5,566 shares (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 613d
  SEC Form 3 filed by new insider Kung Winston

  3 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 676d
  Chief Financial Officer Moran Sean F. exercised 18,043 shares at a strike of $12.96 and sold $863,838 worth of shares (18,043 units at $47.88) (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 676d
  Chief Executive Officer Cohen Yuval exercised 56,179 shares at a strike of $17.14 and sold $2,950,518 worth of shares (63,358 units at $46.57), decreasing direct ownership by 9% to 77,221 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 680d
  Director Holmer Alan F exercised 1,667 shares at a strike of $30.00, increasing direct ownership by 40% to 5,829 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 691d
  Jenkins John Kenneth was granted 2,783 shares, increasing direct ownership by 8,433% to 2,816 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 691d
  Catlin Avery W was granted 2,783 shares, increasing direct ownership by 178% to 4,350 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 691d
  Salzmann Peter was granted 2,783 shares (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 691d
  Jacques Rachelle Suzanne was granted 2,783 shares (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 691d
  Ben Yong was granted 2,783 shares (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 691d
  Holmer Alan F was granted 2,783 shares, increasing direct ownership by 202% to 4,162 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 691d
  Altmeyer Anne was granted 2,783 shares (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 705d
  SEC Form 4 filed by Salzmann Peter

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 705d
  SEC Form 4 filed by Jenkins John Kenneth

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 705d
  SEC Form 4 filed by Jacques Rachelle Suzanne

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 705d
  SEC Form 4 filed by Holmer Alan F

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 705d
  SEC Form 4 filed by Catlin Avery W

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 705d
  SEC Form 4 filed by Ben Yong

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 705d
  SEC Form 4 filed by Altmeyer Anne

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 745d
  Moran Sean F. exercised 1,787 shares at a strike of $30.00, increasing direct ownership by 4% to 48,605 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 775d
  Cormorant Asset Management, Lp bought $23,327,560 worth of shares (550,000 units at $42.41) (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 786d
  Smethurst Dominic was granted 50,000 shares (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 786d
  SEC Form 3 filed by new insider Smethurst Dominic

  3 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 801d
  Moran Sean F. was granted 40,176 shares, increasing direct ownership by 605% to 46,818 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 801d
  Cohen Yuval was granted 73,947 shares, increasing direct ownership by 707% to 84,400 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 809d
  Cormorant Asset Management, Lp bought $14,250,000 worth of shares (750,000 units at $19.00) (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 816d
  Holmer Alan F exercised 629 shares at a strike of $4.97, increasing direct ownership by 84% to 1,379 units (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 816d
  Cohen Yuval exercised 7,179 shares at a strike of $4.97 (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 816d
  Cormorant Asset Management, Lp bought $9,111,941 worth of shares (282,632 units at $32.24) (SEC Form 4)

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 816d
  New insider Cormorant Asset Management, Lp claimed ownership of 442,368 shares (SEC Form 3)

  3 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 1069d
  SEC Form 4 filed by Altmeyer Anne

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)
• 1069d
  SEC Form 4 filed by Jenkins John Kenneth

  4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)